• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Lifeline's MastaScope Featured In Full Page Article in Clinical Lab Products Magazine

Posted on: Monday, 11 July 2005, 12:01 CDT

Lifeline Biotechnologies, Inc. (OTCBB:LBTN) today announced that Louis Keith, MD, PhD, Lifeline's scientific director, was interviewed for a full page article on the company's activities in breast cancer screening and specifically its MastaScope(TM). The article appears in the June 2005 issue of Clinical Lab Products, which is the leading product news magazine for key decision-makers in the clinical diagnostic laboratory, reaching more than 45,000 key individuals. The article can be accessed at the magazine's website: www.clpmag.com/.

The article, by Nicholas Borgert, focuses on the ability of the company's MastaScope product to help detect breast cancer at its earliest stages.

Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's Cancer Detection technologies deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care. The MastaScope(TM) is used in the early detection of cancer and other abnormalities of the breast. The MastaScope(TM) has completed development and has entered the marketplace in the US and internationally. The First Warning System(TM) for assisting in the early detection of breast cancer and the OvaScope(TM) for assisting in the early detection of ovarian cancer are continuing to be developed by the company. More information is available at the company's website: www.lbti.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words, "believe", "expects", "projects", "forecasts", "intends", "will", "anticipated", "could", or "may", and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and are subject to the safe harbor created by the act. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.

Source: Business Wire

More News in this Category